Acute STEMI Treated With Primary Angioplasty and Intravenous 0.5 mg/kg Lovenox or UFH to Lower Ischemic and Bleeding Events.
Phase of Trial: Phase III
Latest Information Update: 03 Jul 2015
At a glance
- Drugs Enoxaparin sodium (Primary) ; Enoxaparin sodium (Primary) ; Heparin; Heparin
- Indications Embolism and thrombosis; Myocardial infarction
- Focus Biomarker; Therapeutic Use
- Acronyms ATOLL
- 03 Jul 2015 Results published in the American Heart Journal.
- 04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
- 29 Aug 2012 Tolerability outcomes (major bleeding complications) presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History